Canadian Rapid Treatment Center of Excellence https://crtce.com/ Champignon develops ketamine and psilocybin derivatives and other psychedelic products from the Company’s IP development platform. Champignon, through its wholly owned subsidiary, the
Canadian Rapid Treatment Center of Excellence Inc., currently operates multidisciplinary community-based clinics offering rapid-onset treatments for depression located in Mississauga, Toronto, and Ottawa and Montreal.